Skip to main content
48°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Tickers
BGNE
BTAI
CCCC
CTXR
Tags
IVBXF
SRRK
CTXR
From
Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
April 05, 2022
Tickers
NVS
Tags
Health Care
Biotech
multiple sclerosis
From
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Tickers
ACAD
ARGX
ATRA
BMY
Tags
FDA
General
ATRA
From
Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
Tickers
ABBV
ALNY
AMGN
APTX
Tags
HCM
BMY
PFE
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Monday, April 4
April 04, 2022
Tickers
AAPL
CRRFY
FRCOY
MMM
Tags
XOM
Market News
Penny Stocks
From
Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
April 04, 2022
Tickers
NVS
Tags
Health Care
Market News
Biotech
From
Benzinga
3 CEOs to Invest In
April 01, 2022
Tickers
ANTM
AXSM
AZN
GH
Tags
JAZZ
GH
ANTM
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
AXSM
SUPN
AMRX
From
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
Tickers
ACMR
AMGN
BABA
BGNE
Tags
NVS
ZLAB
BMY
From
InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
BCLI
Benzinga
News
From
Benzinga
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
March 27, 2022
Tickers
AZN
GRFS
GSK
JNJ
Tags
NVAX
PFE
Market News
From
Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
March 25, 2022
Tickers
NVS
Tags
Health Care
Market News
Biotech
From
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
Tickers
INCY
NVO
NVS
Tags
Recent Press Releases
Market News
NVO
From
Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
Tickers
AMGN
CANF
NVS
Tags
AMGN
General
CANF
From
Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
March 24, 2022
Tickers
NVS
Tags
Health Care
Market News
Biotech
From
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
CODX
News
Benzinga
From
Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
March 22, 2022
Tickers
FUSN
LNTH
NVS
PNT
Tags
General
Benzinga
Plus Therapeutics
From
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Tickers
ADMP
AGTC
ANAB
APTO
Tags
News
Benzinga
APTO
From
Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
March 22, 2022
Tickers
BABA
BYDDY
CP
FB
Tags
Benzinga
PLD
BYDDY
From
Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
March 22, 2022
Tickers
NVS
Tags
NVS
Benzinga
General
From
Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
Tickers
AAPL
AMC
AZN
BABA
Tags
CH:NOVN
INVA
LLY
From
MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
March 19, 2022
Tickers
NVS
PFE
VYGR
Tags
VYGR
Recent Press Releases
PFE
From
Motley Fool
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
NVS
RHHBY
Market News
From
Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
March 14, 2022
Tickers
NVS
Tags
Market News
Biotech
Trading Ideas
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Biotech
Market News
Health Care
From
Benzinga
Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing
March 14, 2022
Tickers
CING
JNJ
NVS
Tags
Benzinga
NVS
JNJ
From
Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
March 14, 2022
Tickers
CRSP
LLY
NVS
VRTX
Tags
CRSP
NVS
VRTX
From
Motley Fool
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
March 11, 2022
Tickers
HCM
JNJ
NVS
Tags
JNJ
NVS
HCM
From
Benzinga
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
March 10, 2022
Tickers
NVS
Tags
Health Care
Biotech
Market News
From
Benzinga
7 Drug Stocks To Consider After the Viatris Plunge
March 10, 2022
Tickers
ABBV
BMY
GSK
JNJ
Tags
NYSE:ABBV,NYSE:BMY,NYSE:GSK,NYSE:JNJ,NYSE:MRK,NYSE:NVS,NYSE:PFE,NYSE:TEVA,NASDAQ:VTRS
ABBV
TEVA
From
InvestorPlace
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.